Free Webex Call
The global cardiac monitoring & cardiac rhythm management devices market is expected to grow at a steady CAGR in the forecast period, 2023-2027. Factors such as the rise in the number of patients suffering from cardiovascular disorders and the growing geriatric population are driving the demand for the global cardiac monitoring & cardiac rhythm management devices market. Emerging economies such as India and China are expected to provide a wide range of growth opportunities for players in the market, which is driven by their large and growing population as well as the increasing number of hospitals and clinics in these countries.Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The global cardiac monitoring & cardiac rhythm management devices market is segmented into cardiac monitoring devices, cardiac rhythm management devices, end user, company, and regional distribution. Based on cardiac monitoring devices, the market is segmented into ECG devices, implantable loop recorders, mobile cardiac telemetry devices, cardiac output monitoring devices, and others. ECG devices dominate the market and are expected to maintain their dominance through the next five years. Growing commercialization of novel products, regional expansions, technological advancements, and government initiatives are the primary factors driving the segment demand. Based on cardiac rhythm management devices, the market is divided into defibrillators and pacemakers. Defibrillators are expected to hold the largest market share in the forecast period, 2023-2027. The surge in the use of cardiac rhythm management devices in countries such as China and India, among others, is influencing the segmental demand.
Major players operating in the global cardiac monitoring & cardiac rhythm management devices market are Abbott Laboratories, Inc., Medtronic PLC, Boston Scientific Corporation, MicroPort Scientific Corporation, GE Healthcare, Koninklijke Philips N.V., Hill-Rom Holdings, Inc., BIOTRONIK, Asahi Kasei Corporation, Nihon Kohden Corporation, Schiller AG, Alivecor, Inc., Metrax GmbH, Shenzhen Mindray Bio-Medical Electronics, and LivaNova PLC. The companies are focusing on extensive research and development activities to stay competitive in the market.
Years considered for this report:
- Historical Years: 2017-2020
- Base Year: 2021
- Estimated Year: 2022E
- Forecast Period: 2023F-2027F
Objective of the Study:
- To analyze historical growth in market size of global cardiac monitoring & cardiac rhythm management devices market from 2017 to 2021.
- To estimate and forecast the market size of global cardiac monitoring & cardiac rhythm management devices market from 2022E to 2027F and growth rate until 2027F.
- To classify and forecast global cardiac monitoring & cardiac rhythm management devices market based on cardiac monitoring devices, cardiac rhythm management devices, end user, company, and regional distribution.
- To identify dominant region or segment in the global cardiac monitoring & cardiac rhythm management devices market.
- To identify drivers and challenges for global cardiac monitoring & cardiac rhythm management devices market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global cardiac monitoring & cardiac rhythm management devices market.
- To identify and analyze the profiles of leading players operating in global cardiac monitoring & cardiac rhythm management devices market.
- To identify key sustainable strategies adopted by market players in global cardiac monitoring & cardiac rhythm management devices market.
The publisher calculated the global cardiac monitoring & cardiac rhythm management devices market size using a bottom-up approach, where data for various regions was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated them through analyzing historical data of these product types and applications for getting an appropriate overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations, and financial reports were also studied by the publisher.
Key Target Audience:
- Cardiac monitoring & cardiac rhythm management devices manufacturers/ suppliers/ distributors
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to cardiac monitoring & cardiac rhythm management devices
- Market research and consulting firms
Report Scope:
In this report, global cardiac monitoring & cardiac rhythm management devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Cardiac Monitoring Devices:
- ECG Devices
- Implantable Loop Recorders
- Mobile Cardiac Telemetry Devices
- Cardiac Output Monitoring Devices
- Others
Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Cardiac Rhythm Management Devices:
- Defibrillators
- Pacemakers
Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By End User:
- Hospitals & Clinics
- Cardiac Care Centers
- Ambulatory Surgery Centers
- Others
Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Region:
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
North America
- United States
- Mexico
- Canada
South America
- Brazil
- Argentina
- Colombia
Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Competitive Landscape
- Company Profiles: Detailed analysis of the major companies present in global cardiac monitoring & cardiac rhythm management devices market.
Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview2. Research Methodology3. Executive Summary4. Voice of Customer5. Impact of COVID-19 on Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market13. Market Trends & Developments15. Strategic Recommendations
6. Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
7. Asia-Pacific Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
8. Europe Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
9. North America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
10. South America Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
11. Middle East and Africa Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
12. Market Dynamics
14. Competitive Landscape
Companies Mentioned
- Abbott Laboratories, Inc
- Medtronic PLC
- Boston Scientific Corporation
- MicroPort Scientific Corporation
- GE Healthcare
- Koninklijke Philips NV
- Hill-Rom Holdings, Inc
- BIOTRONIK
- Asahi Kasei Corporation
- Nihon Kohden Corporation
- Schiller AG
- Alivecor, Inc
- Metrax GmbH
- Shenzhen Mindray Bio-Medical Electronics
- LivaNova PLC